{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:21:02Z","timestamp":1787016062243,"version":"build-2736575974"},"reference-count":26,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2024,11]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Systems for quality and safety assurance in organ donation and transplantation are vital, especially those that seek to minimize donor disease transmission. Australia has developed a national vigilance and surveillance system to identify, review, and analyze actual and potential donor\u2010derived infections and other disease transmissions.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The system involves notification of incidents to the Australian Organ and Tissue Authority for review by a Vigilance and Surveillance Expert Advisory Committee (VSEAC). The VSEAC grades incidents, O makes recommendations, and issues communications both publicly and to the clinical donation and transplant sector.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Annual notifications have increased since the inception of the system in 2012 until 2022. The vast majority relate to procedural aspects including donor assessment, information\/data issues, and the recovery, offer, allocation, preservation and transportation of organs. Possible donor\u2010derived disease accounted for 19% of all notifications, and those related to possible donor\u2010derived infection only 12%. The VSEAC, as a result of reviewing these incidents, has made recommendations resulting in revisions to donor screening, organ allocation, packaging and transportation. The review of incidents has led to changes in clinical guidance for increased viral risk donor assessment, testing, and ensuing organ utilization and recipient surveillance. Guidance has also been reviewed for other infectious risks including strongyloides, human T\u2010lymphotropic virus, and HEV.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The Australian vigilance and surveillance system has enabled national retrospective reporting and evaluation of serious adverse events or reactions to identify trends and inform processes and guidelines, therefore improving the safety of donation and transplantation.<\/jats:p>\n \n \n \n image<\/jats:alt-text>\n <\/jats:graphic>\n <\/jats:boxed-text>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/tid.14315","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:10:07Z","timestamp":1717989007000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surveillance for donor\u2010derived infections in Australia"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-9129","authenticated-orcid":false,"given":"Helen Ingrid","family":"Opdam","sequence":"first","affiliation":[{"name":"Australian Organ and Tissue Authority Canberra Australia"},{"name":"Austin Health Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-0421","authenticated-orcid":false,"given":"Peter","family":"Boan","sequence":"additional","affiliation":[{"name":"Fiona Stanley Hospital Perth Australia"},{"name":"PathWest Laboratory Medicine Western Australia Murdoch Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Barry","sequence":"additional","affiliation":[{"name":"Australian Organ and Tissue Authority Canberra Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8089-2250","authenticated-orcid":false,"given":"Jeremy R","family":"Chapman","sequence":"additional","affiliation":[{"name":"Westmead Hospital Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12851"},{"key":"e_1_2_10_3_1","unstructured":"Global Observatory on Donation and Transplantation (GODT). Accessed March 6 2024.https:\/\/www.transplant\u2010observatory.org\/"},{"key":"e_1_2_10_4_1","unstructured":"Notify Library.The Global Vigilance and Surveillance Database for Medical Products of Human Origin. Accessed February 25 2024.https:\/\/www.notifylibrary.org\/content\/notify\u2010project"},{"key":"e_1_2_10_5_1","unstructured":"Australian Organ and Tissue Donation and Transplantation Authority Strategy 2022\u20132027. Accessed February 25 2024.https:\/\/www.donatelife.gov.au\/sites\/default\/files\/2022\u201008\/OTA%20Strategy%202022\u20102027.pdf"},{"key":"e_1_2_10_6_1","unstructured":"Sixty\u2010third World Health Assembly Human organ and tissue transplantation resolution WHA63.22. 21 May 2010. Accessed February 25 2024.https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63\/A63_R22\u2010en.pdf"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000525129.87363.30"},{"key":"e_1_2_10_8_1","unstructured":"SOHO V&S Guidance for Competent Authorities: Communication and Investigation of Serious Adverse Events and Reactions associated with Human Tissues and Cells. January 2013. Vigilance and Surveillance of Substances of Human Origin (SOHO V&S). A Project funded by the EU Public Health Programme (Project Number: 20091110). Deliverable 8. Accessed February 25 2024.https:\/\/www.notifylibrary.org\/sites\/default\/files\/SOHO%20V%26S%20Communication%20and%20Investigation%20Guidance.pdf"},{"key":"e_1_2_10_9_1","unstructured":"The Notify Booklet: Vigilance and Surveillance (V&S) of medical products of human origin (MPHO). Accessed February 25 2024.https:\/\/www.notifylibrary.org\/content\/booklet\u20102018"},{"key":"e_1_2_10_10_1","first-page":"443","volume-title":"Chapter 16. Biovigilance and surveillance","author":"European Committee on Organ Transplantation","year":"2022"},{"key":"e_1_2_10_11_1","unstructured":"Australian Government Department of Health and Aged Care. Commonwealth Qualified Privilege Scheme. Accessed February 25 2024.https:\/\/www.health.gov.au\/our\u2010work\/commonwealth\u2010qualified\u2010privilege\u2010scheme"},{"key":"e_1_2_10_12_1","unstructured":"Notify Library. The Global Vigilance and Surveillance Database for Medical Products of Human Origin. Accessed February 25 2024.https:\/\/www.notifylibrary.org\/content\/notify\u2010project"},{"key":"e_1_2_10_13_1","unstructured":"Health Insurance (Quality Assurance Activity \u2013 Australian Vigilance and Surveillance System for Organ Donation for Transplantation) Declaration 2021 Administered by the Department of Health and Aged Care Australia. Accessed March 15 2024.https:\/\/www.legislation.gov.au\/F2021L01783\/latest\/text"},{"key":"e_1_2_10_14_1","unstructured":"Australian Government Organ and Tissue Authority DonateLife website Australian Vigilance and Surveillance System for Organ Donation and Transplantation. 2022 Annual Report. Accessed February 25 2024.https:\/\/www.donatelife.gov.au\/for\u2010healthcare\u2010workers\/australian\u2010vigilance\u2010and\u2010surveillance\u2010system\u2010organ\u2010donation\u2010transplantation"},{"key":"e_1_2_10_15_1","unstructured":"Transplantation Society of Australia and New Zealand.Clinical guidelines for organ transplantation from deceased donors. Version 1.12 \u2013 December 2023. Accessed February 25 2024.https:\/\/tsanz.com.au\/storage\/Guidelines\/TSANZ_Clinical_Guidelines_Version\u2010112_06\u2010FINAL\u2010PRINT.pdf"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004074"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.007"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6904a1"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.12868"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(20)30081\u20109"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12482"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13137"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13497"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11673"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12559"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.00453"},{"key":"e_1_2_10_27_1","unstructured":"Notify Library.Vigilance and Inspection for the Safety of Transfusion Assisted Reproduction and Transplantation \u2013 VISTART. Deliverable 5.1 \u2010 How to select and prepare SARE cases of didactic value for insertion in the Notify Library\u2014a user guide for Competent Authorities. Accessed February 25 2024.https:\/\/www.notifylibrary.org\/sites\/default\/files\/USER\u2010GUIDE\u2010FOR\u2010CAs_FINAL%205.1.pdf"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.14315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T11:48:48Z","timestamp":1732103328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.14315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":26,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/tid.14315"],"URL":"https:\/\/doi.org\/10.1111\/tid.14315","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"2024-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14315"}}